T and Leukemic B Cells Aggregate
Showing 9951 - 9975 of >10,000
Obesity Trial in Makassar (Oryza Sativa Extract, Control)
Not yet recruiting
- Obesity
- Oryza Sativa Extract
- Control
-
Makassar, South Sulawesi, IndonesiaHasanuddin University Medical Research Center / HUMRC
Apr 1, 2021
Melanoma (Skin) Trial in Changsha (Peptide, Anti-PD-1, rhGM-CSF)
Unknown status
- Melanoma (Skin)
- Peptide
- +3 more
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Apr 24, 2020
Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Hangzhou (Sintilimab)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 2, 2020
Advanced Hepatocellular Carcinoma Trial in London (Itacitinib (INCB039110))
Recruiting
- Advanced Hepatocellular Carcinoma
- Itacitinib (INCB039110)
-
London, United KingdomImperial College Healthcare NHS Trust
Jul 14, 2022
People Living With HIV Trial in Montreal (Letermovir)
Recruiting
- People Living With HIV
-
Montreal, Quebec, CanadaMcgill University Health Center
Oct 31, 2022
Influenza Trial in Rochester (Seasonal IIV 0.25 mL dose, Natural influenza infection, Seasonal IIV 0.5 mL dose)
Completed
- Influenza
- Seasonal IIV 0.25 mL dose
- +2 more
-
Rochester, New YorkUniversity of Rochester
Aug 5, 2021
Eradication Effect of Helicobacter Pylori Infection
Not yet recruiting
- Helicobacter Pylori Infection
- Amoxicillin + Tetracycline + Bismuth + Esomeprazole
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital, Shandong University
Nov 10, 2022
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
Acne Vulgaris Trial in Abbottabad (25% TRICHLOROACETIC ACID, 30% salicylic acid)
Completed
- Acne Vulgaris
- 25% TRICHLOROACETIC ACID
- 30% salicylic acid
-
Abbottābād, Kpk, PakistanCmh abbottabad
Jan 26, 2023
Influenza Trial in Portland, Temple (Flublok, Flucelvax, Fluarix)
Completed
- Influenza
- Flublok
- +4 more
-
Portland, Oregon
- +1 more
Jul 26, 2022
Executive Function Disorder, Emotional Regulation, Malnutrition, Child Trial in Dhaka (Chickpea based RUSF, E-RUSF, Outcome
Recruiting
- Executive Function Disorder
- +2 more
- Chickpea based RUSF
- +2 more
-
Dhaka, BangladeshInternational Centre for Diarrheal Disease Research
Nov 17, 2022
Skin Aging, Transepidermal Water Loss Trial in Jakarta Pusat (Fractional CO2 Laser, Microneedle)
Not yet recruiting
- Skin Aging
- Transepidermal Water Loss
- Fractional CO₂ Laser
- Microneedle
-
Jakarta Pusat, DKI Jakarta, IndonesiaFaculty of Medicine, Universitas Indonesia
Aug 18, 2022
Allergy;Food, Wheat Allergy, Children Trial in Hong Kong (Wheat-containing food)
Not yet recruiting
- Allergy;Food
- +2 more
- Wheat-containing food
-
Hong Kong, Hong KongDepartment of Pediatrics, 6/F, Lui Che Woo Clinical Sciences Bui
Oct 5, 2023
ARDS Trial in Nanjing
Recruiting
- ARDS
-
Nanjing, Jiangsu, ChinaNanjing Zhong-Da Hospital, Southeast University
Jul 17, 2022
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis Flare Trial in Copenhagen NV (Dicloxacillin Oral Capsule, Elocon
Recruiting
- Atopic Dermatitis
- +2 more
- Dicloxacillin Oral Capsule
- Elocon 0.1 % Topical Cream
-
Copenhagen NV, DenmarkDepartment of Dermatology
Dec 20, 2022
ADHDs Trial in Vancouver (Psychostimulants)
Active, not recruiting
- Attention Deficit Hyperactivity Disorders
-
Vancouver, British Columbia, CanadaDevelopmental Cognitive Neuroscience Lab, Department of Psychiat
May 16, 2022
Oral Lichen Planus Trial (6-Gingerol, Triamcinolone Acetonide 0.1% Oromucosal Paste)
Not yet recruiting
- Oral Lichen Planus
- 6-Gingerol
- Triamcinolone Acetonide 0.1% Oromucosal Paste
- (no location specified)
May 22, 2023
Small Cell Lung Cancer Trial in New Haven (Combination immunotherapy with Ipilimumab and Nivolumab)
Active, not recruiting
- Small Cell Lung Cancer
- Combination immunotherapy with Ipilimumab and Nivolumab
-
New Haven, ConnecticutYale University, Yale Cancer Center
Apr 21, 2022
Spinal Cord Injuries Trial in Boston (Testosterone Undecanoate, hybrid exercise)
Recruiting
- Spinal Cord Injuries
- Testosterone Undecanoate
- hybrid exercise
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 11, 2022
Expression of Endometrium During Window of Implantation
Recruiting
- Unrecognized Condition
-
Kaohsiung City, TaiwanKaohsiung Veterans General Hospital
Jul 27, 2022
Long COVID Trial in Milan (VSL#3®, Placebo)
Recruiting
- Long COVID
- VSL#3®
- Placebo
-
Milan, MI, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
May 22, 2023
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United
Recruiting
- Embryonal Rhabdomyosarcoma
- +2 more
- Cyclophosphamide
- +3 more
-
Birmingham, Alabama
- +47 more
Aug 17, 2022
Breastfeeding, Exclusive, HIV Trial (Mobile phone text messaging plus prospective motivational interviewing, Standard infant
Recruiting
- Breastfeeding, Exclusive
- HIV Infections
- Mobile phone text messaging plus prospective motivational interviewing
- Standard infant feeding counselling
-
Cape Town, Western Cape, South AfricaKhayelitsha District Hospital
Nov 24, 2022
Epithelial Ovarian Cancer Trial in Singapore (Oregovomab, Nivolumab, Chemotherapy)
Unknown status
- Epithelial Ovarian Cancer
- Oregovomab
- +2 more
-
Singapore, Singapore
- +1 more
Nov 30, 2021